MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/cancers17050762

Медицинская библиотека · Cancers · 2025

Apparent Diffusion Coefficient as an Early Predictive Factor of Local and Overall Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate Cancer.

Duque-Santana Victor, Fernandez Julio, Diaz-Gavela Ana, Recio Manuel, Guerrero Luis L, Peña Marina, Sanchez Sofia, López-Campos Fernando, Thuissard Israel J, Andreu-Vázquez Cristina, Sanz-Rosa David, Achard Vérane, Gómez-Iturriaga Alfonso, Díez Víctor, Jereczek-Fossa Barbara A, Del Cerro Elia, Couñago Felipe

СтатьяПеревод пока не подготовлен

Аннотация

Background/

Objectives

To analyze the predictive value of the apparent diffusion coefficient (ADC) in patients with prostate cancer (PCa) treated with radiotherapy (RT) and androgen deprivation therapy (ADT).

Methods

Retrospective study of patients with high-risk, very high-risk, or unfavorable intermediate-risk PCa who received RT and ADT between 2008 and 2019 and underwent multiparametric magnetic resonance imaging mpMRI) at 6 months post-RT. Differences in ADC values were compared between patients with and without progression and/or local recurrence. Receiver operating characteristic (ROC) curves were used to obtain ADC cutoffs for predicting 10-year progression-free-survival (PFS) and local recurrence-free survival (LRFS).

Results

We evaluated 98 patients (73 [74.5%] high-risk). Over a mean ± SD follow-up of 95.36 ± 30.54 months, 19 patients (19.4%) progressed; at 10 years, PFS was 75.6%, LRFS 93.8%, metastasis-free survival 85.5%, and overall survival 89.5%. Post-RT ADC was significantly lower in patients with local recurrence (1.09 ± 0.18 vs. 1.30 ± 0.20 × 10-3 mm2/s, p = 0.020) and progression (1.23 ± 0.20 vs. 1.30 ± 0.21 × 10-3 mm2/s, p = 0.004). ROC analysis identified a post-RT ADC cutoff of 1.11 × 10-3 mm2/s for local recurrence (area under curve [AUC] 0.843, sensitivity 89.4%, positive predictive value [PPV] 98.8%). The cutoff for progression was 1.24 × 10-3 mm2/s (AUC0.705, sensitivity 72.2%, PPV87.7%). Patients with a post-RT ADC value below and above 1.11 × 10-3 mm2/shad a 10-year LRFS of 66.8% and 97.7%, respectively (HR: 25.04 [2.58-242.92], p < 0.001). The corresponding rates for 10-year PFS were 58.6% and 85.6% in patients with post-RT ADC values below and above 1.24 × 10-3 mm2/s (HR: 2.916 [1.113-7.644], p = 0.015). In the multivariate analysis, a post-treatment ADC value ≤ 1.24 × 10-3 mm2/s was a significant prognostic factor for a lower PFS (HR: 3823 [1371-10,657], p = 0.010).

Conclusions

This is the first study to show that post-RT ADC can be a predictive factor of local recurrence in PCa treated with RT and ADT. Moreover, this long-term study demonstrates its value as a predictive factor of progression in PCa treated with RT and ADT.

Для цитирования: Duque-Santana Victor, Fernandez Julio, Diaz-Gavela Ana, Recio Manuel, Guerrero Luis L, Peña Marina, Sanchez Sofia, López-Campos Fernando, Thuissard Israel J, Andreu-Vázquez Cristina, Sanz-Rosa David, Achard Vérane, Gómez-Iturriaga Alfonso, Díez Víctor, Jereczek-Fossa Barbara A, Del Cerro Elia, Couñago Felipe. Apparent Diffusion Coefficient as an Early Predictive Factor of Local and Overall Response to Treatment with Androgen Deprivation Therapy and Radiotherapy in Patients with Prostate Cancer.. Cancers. 2025. DOI: 10.3390/cancers17050762.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.